Home » Results of Lymphoseek Phase III Clinical Trials in Melanoma Published in Annals of Surgical Oncology
Results of Lymphoseek Phase III Clinical Trials in Melanoma Published in Annals of Surgical Oncology
Navidea Biopharmaceuticals announced the peer-reviewed publication of results from two Phase III clinical trials of Lymphoseek (technetium 99m tilmanocept) in patients with melanoma of the skin.
Daily Finance
Daily Finance
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May